Philogen S.p.A. (BIT:PHIL)
Italy · Delayed Price · Currency is EUR 23.50
-0.40 (-1.67%)
Oct 23, 2025, 10:32 AM CET
Philogen Revenue
Philogen had revenue of 8.53M EUR in the half year ending June 30, 2025, a decrease of -61.82%. This brings the company's revenue in the last twelve months to 84.66M, up 2,060.30% year-over-year. In the year 2024, Philogen had annual revenue of 77.65M with 213.99% growth.
Revenue (ttm)
84.66M
Revenue Growth
+2,060.30%
P/S Ratio
11.37
Revenue / Employee
421.20K
Employees
183
Market Cap
962.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77.65M | 52.92M | 213.99% |
| Dec 31, 2023 | 24.73M | -2.21M | -8.20% |
| Dec 31, 2022 | 26.94M | 21.98M | 442.71% |
| Dec 31, 2021 | 4.96M | -1.38M | -21.77% |
| Dec 31, 2020 | 6.35M | -8.71M | -57.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B |
| Amplifon | 2.41B |
| DiaSorin | 1.22B |
| Safilo Group | 998.89M |
| EL.En. | 579.71M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 474.78M |
| Svas Biosana | 134.95M |